Atractylenolide III

CAS No. 73030-71-4

Atractylenolide III ( ICodonolactone; 8β-Hydroxyasterolide )

Catalog No. M19046 CAS No. 73030-71-4

Atractylenolide III may have therapeutic potential in treating homocysteine-mediated cognitive impairment and neuronal injury.

Purity : 98%

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 56 In Stock
5MG 101 In Stock
10MG 182 In Stock
25MG 328 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Atractylenolide III
  • Note
    Research use only, not for human use.
  • Brief Description
    Atractylenolide III may have therapeutic potential in treating homocysteine-mediated cognitive impairment and neuronal injury.
  • Description
    Atractylenolide III may have therapeutic potential in treating homocysteine-mediated cognitive impairment and neuronal injury. Atractylenolide III is a potential candidate for the treatment of human lung carcinoma by inducing the release of cytochrome c, upregulating the expression of Bax and translocating apoptosis-inducing factor.
  • Synonyms
    ICodonolactone; 8β-Hydroxyasterolide
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Apoptosis inducer
  • Research Area
    Cancer
  • Indication
    ——

Chemical Information

  • CAS Number
    73030-71-4
  • Formula Weight
    248.32
  • Molecular Formula
    C15H20O3
  • Purity
    98%
  • Solubility
    DMSO : ≥ 100 mg/mL; 402.71 mM
  • SMILES
    C=C1CCC[C@]2([C@H]1CC1=C(C)C(=O)O[C@]1(C2)O)C
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Zhao H,et al. Neuroscience. 2015 Apr 2;290:485-91.
molnova catalog
related products
  • Mc-Val-Cit-PAB-Cl

    Mc-Val-Cit-PAB-Cl can be used to conjugate MMAE and antibody to form antibody-MC-vc-MMAE.

  • Peucedanocoumarin II

    Peucedanocoumarin II shows only partial relaxation.

  • BPH-1358

    BPH-1358 (NSC50460) is a potent human farnesyl diphosphate synthase (FPPS) and undecaprenyl diphosphate synthase (UPPS) inhibitor.